Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1123-1127

  Pérez Melgosa, Mercedes ^a   Hollenbaugh, Diane ^b   Wilson, Christopher B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN; MESSENGER RNA; PICRIC ACID; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, T-INDEPENDENT; CD40 LIGAND; FICOLL; HAPTENS; HEMOCYANIN; HUMANS; IMMUNOGLOBULIN M; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PICRATES; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TRINITROBENZENES;

EID: 0345593708     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. + T cells. J. Immunol. 151:2497.
2. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
3. Seyama, K., S. Nonoyama, I. Gangsaas, D. Hollenbaugh, H. F. Pabst, A. Aruffo, and H. D. Ochs. 1998. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421.
4. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
5. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
6. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. [Published erratum appears in 1994 Immunity 1:613.] Immunity 1:423.
7. Northrop, J. P., G. R. Crabtree, and P. S. Mattila. 1992. Negative regulation of interleukin 2 transcription by glucocorticoid receptor. J. Exp. Med. 175:1235.
8. Brombacher, F., T. Schafer, U. Weissenstein, C. Tschopp, E. Andersen, K. Burki, and G. Baumann. 1994. IL-2 prometer-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cell of transgenic mice. Int. Immunol. 6:189.
9. Iritani, B. M., K. A. Forbush, M. A. Farrar, and R. M. Perlmutter. 1997. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16: 7019.
10. Hogan, B., R. Beddington, F. Constanini, and E. E. Lacy. 1994. Produciton of transgenic mice. In Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, pp. 217-248.
11. Browstone, A., N. A. Mitchison, and R. Pitt-Rivers. 1966. Immunological determinant 4-hidroxy-3-iodo-5 nitrophenylacetic acid (NIP) and related compounds. Immunology 10:465.
12. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
13. Lewis, D. B., A. Larsen, and C. B. Wilson. 1986. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J. Exp. Med. 163:1018.
14. Hagenbaugh, A., S. Sherven, S. Dubinett, S. H.-Y. Wei, R. Aranda, H. Cheroutre, D. J. Fowell, S. Binder, B. Tsao, R. M. Locksley, K. W. Moore, and M. Kronenberg. 1997. Altered immune responses in interleukin 10 transgenic mice. J. Exp. Med. 185:2101.
15. Graf, D., S. Muller, U. Korthauer, C. Van-Kooten, C. Weise, and R. A. Krockek. 1995. A soluble form of TRAP(CD40 ligand) is rapidly release after T cell activation. Eur. J. Immunol. 25:1749.
16. Gurunathan, S., K. R. Irvine, C. Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder. 1998. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161:4563.
17. Dullforce, P., D. C. Sutton, and A. W. Heath. 1998. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nat. Med. 4:88.
18. Van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1.
19. Van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
20. Kennedy, M. K., K. M. Mohler, K. D. Shanebeck, P. R. Baum, K. S. Picha, E. C. Otten, C. J. Janeway, and K. H. Grabstein. 1994. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24:113.
21. Noelle, R. J., J. A. Ledbetter, and A. Araffo. 1992. CD40 and its ligand and essential ligand-receptor pair for thymus-dependent B cell activation. Immunol. Today 13:431.
22. Dunn, R. J., C. J. Luedecker, H. S. Haugen, C. H. Clegg, and A. G. Farr. 1997. Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization. J. Histochem. Cytochem. 45:129.
23. Brown, M. P., D. J. Topham, M. Y. Sangster, J. Zhao, K. J. Flynn, S. L. Surman, D. L. Woodland, P. C. Doherty, A. G. Farr, P. K. Pattengale, and M. K. Brenner. 1998. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat. Med. 4:1253.
24. Flamand, V., V. Donckier, F. X. Demoor, A. Le Moine, P. Matthys, M. L. Vanderhaeghen, Y. Tagawa, Y. Iwakura, A. Billiau, D. Abramowicz, and M. Goldman. 1998. CD40 ligation prevents neonatal induction of transplantation tolerance. J. Immunol. 160: 4666.
25. Nonoyama, S., L. A. Penix, C. P. Edwards, D. B. Lewis, S. Ito, A. Aruffo, C. B. Wilson, and H. D. Ochs. 1995. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95:66.
26. Durandy, A., G. De Saint-Basile, B. Lisowska-Grospieire, J. F. Gauchat, M. Forveille, R. A. Kroczek, J. Y. Bonnefoy, and A. Fischer. 1995. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 154:1560.
27. Jaiswal, A. I., and M. Croft. 1997. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. J. Immunol. 159:2282.
28. Kovarik, J., and C. A. Siegrist. 1998. Immunity in early life. Immunol. Today 19:15.
29. Barrios, C., C. Brandt, M. Berney, P. H. Lambert, and C. A. Siegrist. 1996. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 26:2666.
30. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723.
31. + T-helper and a T-killer cell. Nature 393: 474.